[ad_1]
(HealthDay)—A medication reduction strategy is safe among some older adults treated with antihypertensives, according to a study published in the May 26 issue of the Journal of the American Medical Association.
James P. Sheppard, Ph.D., from the University of Oxford in the United Kingdom, and colleagues evaluated whether antihypertensive medication reduction is possible in patients ≥80 years without significant changes in systolic blood pressure (BP) control or adverse events during 12-week follow-up. Patients (48.5 percent women) were randomly assigned to either antihypertensive medication reduction (removal of one drug [intervention], 282) or usual care (control, 287).
At baseline, patients were prescribed a median of two antihypertensive medications. At 12 weeks, 86.4 percent of patients in the intervention group and 87.7 percent of patients in the control group had a systolic BP control group (adjusted relative risk, 1.72; 95 percent confidence interval, 0.7 to 4.3).
“The findings suggest antihypertensive medication reduction can be achieved without substantial change in BP control in some older patients with hypertension,” the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
CDC: Overall prevalence of self-reported hypertension 32.4 percent
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Copyright © 2020 HealthDay. All rights reserved.
Citation:
Reducing number of BP meds may be safe in some older adults (2020, June 3)
retrieved 3 June 2020
from https://medicalxpress.com/news/2020-06-bp-meds-safe-older-adults.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
